Fidelity Investments
IMCR icon

Fidelity Investments’s Immunocore IMCR Stock Holding History

Fidelity Investments’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$137M Sell
4,307,246
-521,908
-11% -$15.4M 0.01% 1102
2026
Q1 		$146M Buy
4,829,154
+289,929
+6% +$9.38M 0.01% 1005
2025
Q4 		$158M Buy
4,539,225
+118,822
+3% +$4.19M 0.01% 970
2025
Q3 		$161M Sell
4,420,403
-435,369
-9% -$14.8M 0.01% 945
2025
Q2 		$152M Buy
4,855,772
+15,276
+0.3% +$475K 0.01% 936
2025
Q1 		$144M Buy
4,840,496
+22,797
+0.5% +$684K 0.01% 940
2024
Q4 		$142M Sell
4,817,699
-18,341
-0.4% -$580K 0.01% 970
2024
Q3 		$151M Buy
4,836,040
+23,436
+0.5% +$852K 0.01% 933
2024
Q2 		$163M Buy
4,812,604
+500,460
+12% +$25.5M 0.01% 854
2024
Q1 		$280M Buy
4,312,144
+2,615,758
+154% +$180M 0.02% 657
2023
Q4 		$116M Sell
1,696,386
-439,837
-21% -$22.9M 0.01% 956
2023
Q3 		$111M Buy
2,136,223
+90,116
+4% +$5.33M 0.01% 924
2023
Q2 		$123M Sell
2,046,107
-43,444
-2% -$2.48M 0.01% 906
2023
Q1 		$103M Buy
2,089,551
+85,638
+4% +$4.82M 0.01% 976
2022
Q4 		$114M Buy
2,003,913
+610,679
+44% +$34.4M 0.01% 921
2022
Q3 		$65.4M Buy
1,393,234
+32,850
+2% +$1.57M 0.01% 1133
2022
Q2 		$50.8M Sell
1,360,384
-267,171
-16% -$8.68M 0.01% 1254
2022
Q1 		$48.7M Sell
1,627,555
-495,772
-23% -$12.5M ﹤0.01% 1399
2021
Q4 		$72.7M Sell
2,123,327
-57,659
-3% -$2.09M 0.01% 1262
2021
Q3 		$80.8M Buy
2,180,986
+949,142
+77% +$32M 0.01% 1195
2021
Q2 		$48.1M Sell
1,231,844
-189,293
-13% -$7.31M ﹤0.01% 1453
2021
Q1 		$60.5M Buy
+1,421,137
New +$63.3M 0.01% 1305

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

Fidelity Investments's IMCR Position: Q2 2026 in Review

Fidelity Investments reduced its Immunocore (IMCR) stake by 11% in Q2 2026, selling an estimated $15.4M and leaving 4,307,246 shares worth $137M. The position accounts for 0.01% of the portfolio, ranked #1102.

Fidelity Investments first reported a position in IMCR in Q1 2021 and has held it in 22 quarters since. The position peaked at $280M in Q1 2024. 136 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • Fidelity Investments held 4,307,246 shares of Immunocore worth $137M as of Q2 2026.
  • Fidelity Investments sold 521,908 Immunocore shares in Q2 2026, an estimated $15.4M.
  • Immunocore made up 0.01% of Fidelity Investments's portfolio in Q2 2026, its #1102 holding.
  • Fidelity Investments first reported a position in Immunocore in Q1 2021 and has held it in 22 quarters since.
  • Fidelity Investments's Immunocore position peaked at $280M in Q1 2024.
  • 136 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.